Research finds low ESRP2 levels linked to RNA splicing errors in liver cells — Evidence Review
Published in Nature Communications, by researchers from University of Illinois Urbana-Champaign, Duke University, Chan Zuckerberg Biohub Chicago, Johns Hopkins University Hospital
Researched by
— the AI search engine for science
Table of Contents
Excessive alcohol use impairs the liver’s natural healing by trapping cells in an abnormal regenerative state, a finding highlighted by new research from the University of Illinois Urbana-Champaign and collaborators. Related studies generally support the role of disrupted RNA splicing and loss of ESRP2 in liver disease progression and regeneration failure.
- Several prior studies demonstrate that ESRP2 is a central regulator of alternative splicing in liver cells and its loss is linked to the shift toward immature, non-functional cell states, supporting the new findings 1 2 4.
- Research also indicates that inflammation, often triggered by alcohol or chronic injury, can downregulate ESRP2 and other splicing factors, further impairing liver regeneration and function 4 11.
- Related work in both alcoholic and nonalcoholic liver disease confirms that restoring splicing factor expression or targeting inflammatory pathways may offer therapeutic potential 5 12 13.
Study Overview and Key Findings
Disorders of liver regeneration are a leading cause of morbidity and mortality in individuals with alcohol-associated liver disease, yet the molecular reasons for failed healing have remained unclear. This study addresses a critical gap by identifying how chronic alcohol exposure, and the resulting inflammation, disrupts RNA splicing in liver cells—specifically by lowering levels of the splicing regulator ESRP2. The findings highlight a mechanism by which liver cells become trapped in an unproductive, intermediate state, unable to fully regenerate even after alcohol cessation, and suggest new pathways for diagnosis and therapy.
| Property | Value |
|---|---|
| Organization | University of Illinois Urbana-Champaign, Duke University, Chan Zuckerberg Biohub Chicago, Johns Hopkins University Hospital |
| Journal Name | Nature Communications |
| Authors | Auinash Kalsotra, Anna Mae Diehl, Ullas Chembazhi, Sushant Bangru |
| Population | Liver tissue from people with alcohol associated hepatitis or cirrhosis |
| Methods | Animal Study |
| Outcome | RNA splicing errors, liver cell regeneration failure |
| Results | Low ESRP2 levels linked to widespread RNA missplicing in liver cells. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus database, which includes over 200 million research papers. The following search queries were used:
| Topic | Key Findings |
|---|---|
| How does ESRP2-mediated splicing affect liver regeneration and disease? | - ESRP2 orchestrates the switch from fetal to adult splicing isoforms in hepatocytes, which is essential for postnatal liver maturation and regeneration 2. - Loss or suppression of ESRP2 triggers reprogramming of adult hepatocytes into fetal-like cells, contributing to liver dysfunction and disease 4. |
| What is the impact of alcohol and inflammation on RNA splicing in the liver? | - Chronic alcohol exposure and inflammation suppress ESRP2 and other splicing factors, leading to widespread RNA missplicing that impairs regeneration and function 4 11. - Inflammatory cytokines released during liver injury can drive splicing changes that promote immature or dysfunctional cell states 4 11. |
| Can restoring RNA splicing or targeting splicing factors offer new therapies? | - Restoring splicing factor function or blocking inflammatory pathways that disrupt splicing may improve liver regeneration and disease outcomes 12 13. - Modulating splicing regulators like ESRP2 or SRSF3 shows potential for reversing liver dysfunction in both alcoholic and nonalcoholic liver diseases 11 12. |
| Does alcohol abstinence improve liver recovery and outcomes? | - Alcohol abstinence is associated with improved prognosis and reduced progression of liver disease, but certain molecular changes—such as splicing errors—may persist and limit full recovery in advanced disease 9 10. - Integrated management of alcohol use disorder improves liver-related outcomes in affected patients 8. |
How does ESRP2-mediated splicing affect liver regeneration and disease?
Multiple studies have established ESRP2 as a pivotal regulator of alternative splicing in hepatocytes, controlling the shift from fetal to adult gene expression programs. The new study's findings that loss of ESRP2 traps liver cells in a dysfunctional state echo and expand upon this prior work.
- ESRP2 drives the neonatal-to-adult splicing transition in hepatocytes, which is required for proper liver maturation and function 2.
- Suppression or deletion of ESRP2 results in a failure to generate adult splice isoforms, leaving cells in an immature state and impairing regeneration 2 4.
- In severe alcoholic hepatitis and hepatocellular carcinoma, loss of ESRP2 reprograms hepatocytes toward fetal-like gene expression, contributing to disease progression 4 5.
- The current study provides direct evidence that ESRP2 deficiency, triggered by alcohol-induced inflammation, underlies regeneration failure in human liver disease, reinforcing earlier findings 2 4.
What is the impact of alcohol and inflammation on RNA splicing in the liver?
The link between alcohol consumption, inflammation, and RNA splicing disruption is well-documented. The new research builds on these findings by elucidating how inflammation specifically suppresses ESRP2, leading to widespread splicing errors.
- Inflammatory cytokines released in response to alcohol-induced liver injury downregulate ESRP2, driving a fetal-like splicing program 4 11.
- Disruption of other splicing factors (e.g., SRSF3, SRSF6) through inflammation or metabolic stress also results in impaired liver function and regeneration 11 13.
- The new study demonstrates that blocking inflammatory signals can restore ESRP2 levels and normalize RNA splicing, suggesting a mechanistic link 4 11.
- These findings underscore the importance of inflammation in modulating RNA processing and liver cell identity during chronic injury 4 11.
Can restoring RNA splicing or targeting splicing factors offer new therapies?
Emerging evidence supports the therapeutic potential of targeting RNA splicing pathways or their regulators in liver disease. The new study’s demonstration that blocking inflammation can restore splicing factor levels adds to this growing field.
- Restoration of core transcription factors and splicing regulators improves liver function and reverses chronic injury in experimental models 12.
- Preventing the degradation or loss of splicing factors like SRSF3 or ESRP2 partially protects against fibrosis, inflammation, and regeneration failure 11 12.
- Targeting fetal-like splicing programs in hepatocellular carcinoma by modulating ESRP2 can slow tumor progression 5.
- The use of anti-inflammatory agents to indirectly restore normal splicing is suggested as a therapeutic avenue in the new study and related research 4 13.
Does alcohol abstinence improve liver recovery and outcomes?
Alcohol abstinence is widely recognized as the most effective intervention for alcohol-associated liver disease, but molecular impairments may persist and limit recovery in advanced disease, as highlighted by both the new research and related studies.
- Cohort and meta-analysis studies show improved survival and decreased liver complications with abstinence, across all stages of cirrhosis and portal hypertension 9 10.
- Integrated management of alcohol use disorder and liver disease improves patient outcomes and reduces mortality 8.
- Despite abstinence, advanced liver disease patients may not fully recover due to persistent molecular changes such as RNA missplicing and loss of cell identity 10 12.
- The current study suggests that therapies targeting splicing or inflammation may be needed to supplement abstinence in severe cases 4 12.
Future Research Questions
While recent findings have advanced understanding of the molecular disruptions driving liver regeneration failure, key questions remain regarding long-term outcomes, therapeutic interventions, and the reversibility of splicing defects. Further research is needed to clarify these gaps and inform targeted treatments.
| Research Question | Relevance |
|---|---|
| Can targeting inflammatory pathways restore ESRP2 levels and improve liver regeneration in humans? | Determining whether anti-inflammatory treatments can restore ESRP2 and normal splicing in human patients could validate a new therapeutic approach for advanced liver disease 4 12. |
| Are RNA splicing errors reversible after long-term alcohol cessation? | This question addresses whether molecular defects persist even after abstinence, influencing recovery and treatment strategies in alcohol-associated liver disease 9 10 12. |
| Can mis-spliced RNA molecules serve as reliable biomarkers for early detection of liver disease? | Early identification of at-risk patients could be improved with molecular diagnostics, enabling earlier intervention and improved outcomes 4 7. |
| What is the role of other splicing factors like SRSF3 in alcohol-related liver disease? | Understanding if additional splicing regulators contribute to disease progression may reveal synergistic or alternative therapeutic targets 11 13. |
| Does combining anti-inflammatory therapy with alcohol abstinence improve liver outcomes compared to abstinence alone? | This question examines whether a dual approach could enhance liver regeneration and recovery, especially in patients with advanced disease who do not fully recover with abstinence alone 8 10. |